Dale Curtis Hogue Jr.
CIK: 0002006649
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
TCRT
Alaunos Therapeutics, Inc.
DirectorOfficer
Discretionary Trading P&L
Holdings
About Hogue Dale Curtis Jr.
Hogue Dale Curtis Jr. (SEC CIK 0002006649) files insider reports with the SEC as Director of Alaunos Therapeutics, Inc. (TCRT).
Signal8 holds 1 ownership filing by Hogue Dale Curtis Jr., a Form 4, filed on Apr 1, 2025. Those filings report 1 transaction, the latest on Mar 29, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Hogue Dale Curtis Jr.'s filings is in HOUSTON, TX.
Recent filings by Hogue Dale Curtis Jr.
- Mar 29, 2025: Grant or award of TCRT derivative securities (Form 4, code A).
Other insiders filing for Alaunos Therapeutics, Inc. (TCRT)
- Fairmount Funds Management LLC, Director
- Weis Holger, CEO
- Vieser Jaime, Director
- Postma Robert W, Director
- Jerman Michael Allen, Director
- Groenewald Ferdinand, VP, Finance